New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Mudalungu, Cynthia Muhavi (VerfasserIn)
Format: Abschlussarbeit Buch
Sprache:English
Veröffentlicht: Berlin 2018
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Abstract
Inhaltsverzeichnis
Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 c 4500
001 BV045145837
003 DE-604
005 00000000000000.0
007 t|
008 180823s2018 gw |||| m||| 00||| eng d
015 |a 18,H08  |2 dnb 
016 7 |a 1161487891  |2 DE-101 
035 |a (OCoLC)1136393167 
035 |a (DE-599)DNB1161487891 
040 |a DE-604  |b ger  |e rda 
041 0 |a eng 
044 |a gw  |c XA-DE 
049 |a DE-83 
100 1 |a Mudalungu, Cynthia Muhavi  |e Verfasser  |0 (DE-588)1165269198  |4 aut 
245 1 0 |a New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species  |c vorgelegt von M.Sc. Cynthia Muhavi Mudalungu, aus Kakamega, Kenia 
264 1 |a Berlin  |c 2018 
300 |a vi, 134 Seiten  |b Diagramme  |c 21 cm 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
502 |b Dissertation  |c Technische Universität Berlin  |d 2018 
655 7 |0 (DE-588)4113937-9  |a Hochschulschrift  |2 gnd-content 
856 4 2 |m B:DE-101  |q application/pdf  |u http://d-nb.info/1161487891/04  |3 Inhaltsverzeichnis 
856 4 |u http://verlag.tu-berlin.de/abstracts/diss/mudalungu_cynthia_abstract.pdf  |3 Abstract 
856 4 |u http://verlag.tu-berlin.de/abstracts/diss/mudalungu_cynthia_inhalt.pdf  |3 Inhaltsverzeichnis 
856 4 2 |m DNB Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030535590&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
943 1 |a oai:aleph.bib-bvb.de:BVB01-030535590 

Datensatz im Suchindex

_version_ 1819756067017457664
adam_text TABLE OF CONTENTS ABBREVIATIONS.........................................................................................................................................I LIST OF FIGURES........................................................................................................................................III LIST OF TABLES.........................................................................................................................................VI 1 INTRODUCTION............................................................................................................................... 1 1.1 NATURAL PRODUCTS AND THEIR PHARMACOLOGICAL RELEVANCE .............................................. 1 1.1.1 SOME NOVEL METABOLITES FROM UNDEREXPLORED SOURCES ........................................ 2 1.1.2 SELECTED CLASSES OF PATHWAY-SPECIFIC SECONDARY METABOLITES .......................... 3 1.1.2.1 PEPTIDES.........................................................................................................3 1.1.2.2 POLYKETIDES.................................................................................................... 6 1.1.2.3 TERPENES....................................................................................................... 7 1.2 RECENT ADVANCES TOWARDS DISCOVERY OF NOVEL BIOACTIVE METABOLITES ......................... 8 1.2.1 UNCULTURED ORGANISMS AND NEW ECOLOGICAL NICHES ............................................... 9 1.2.2 BIOINFORMATICS.....................................................................................................10 1.3 THE PHYLUM BASIDIOMYCOTA.........................................................................................10 1.3.1 CYATHANE DITERPENOID METABOLITES .................................................................... 11 1.4 THE GENUS STREPTOMYCES AND SOME OF ITS IMPORTANT METABOLITES...............................12 1.5 ESSENTIAL TOOLS SUPPORTING THE DISCOVERY OF NOVEL METABOLITES ................................ 13 1.5.1 MASS SPECTROMETRY (MS).....................................................................................13 1.5.2 GENOME MINING...................................................................................................13 1.5.3 NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY .......................................... 14 2 AIM OF THE STUDY.................................................................................................................... 15 2.1 OBJECTIVES 15 3 MATERIALS...................................................................................................................................16 3.1 EQUIPMENT AND SOFTWARE.............................................................................................16 3.1.1 EQUIPMENT............................................................................................................16 3.1.2 SOFTWARE...............................................................................................................18 3.2 CHEMICALS..................................................................................................................... 18 3.3 MICROORGANISMS...........................................................................................................19 3.4 CULTURE MEDIA TYPES.....................................................................................................21 3.5 BUFFERS AND SOLUTIONS...................................................................................................22 4 METHODS....................................................................................................................................23 4.1 ISOLATION AND CHARACTERIZATION OF LAXITEXTINE COMPOUNDS FROM LAXITEXTUM INCRUSTATUM (BASIDIOMYCOTA)................................................................................................23 4.1.1 STRAIN COLLECTION AND CHARACTERIZATION ................................................................ 23 4.1.2 FERMENTATION OF LAXITEXTUM INCRUSTATUM (STMA 14285) ................................... 23 4.1.3 EXTRACTION AND ISOLATION........................................................................................24 4.1.4 THE ANALYTICAL TECHNIQUES USED IN STRUCTURE ELUCIDATION.....................................24 4.1.5 ANTIBACTERIAL ASSAYS..............................................................................................25 4.1.6 CYTOTOXICITY ASSAYS...............................................................................................25 4.2 ISOLATION AND CHARACTERIZATION OF THE STREPTOMYCES-DERIVED METABOLITES ................. 25 4.2.1 ISOLATION OF THE ANGUCYCLINONE AND ANTHRACYCLINE COMPOUNDS..........................25 4.2.1.1 CULTIVATION, EXTRACTION AND FRACTIONATION....................................................25 4.2.1.2 PURIFICATION OF THE ANGUCYCLINONE................................................................ 26 4.2.1.3 PURIFICATION OF THE ANTHRACYCLINES ................................................................ 26 4.2.2 ISOLATION OF THE NOURSAMYCIN COMPOUNDS........................................................... 27 4.2.2.2 PURIFICATION OF THE NOURSAMYCINS...............................................................27 4.2.3 ISOLATION OF THE LINARIDIN PEPTIDES ..................................................................... 28 4.2.3.1 CULTIVATION, EXTRACTION AND FRACTIONATION ................................................... 28 4.2.3.2 PURIFICATION OF THE LINARIDINS ....................................................................... 28 4.2.4 HPLC-MS ANALYSES..............................................................................................29 4.2.5 MALDI-TOF/TOF-MS ANALYSIS ............................................................................. 30 4.2.6 MS/MS ANALYSIS AND SPECTRAL NETWORKING .......................................................... 30 4.2.7 AMINO ACID ANALYSIS.............................................................................................30 4.2.8 NMR SPECTROSCOPIC ANALYSIS ............................................................................... 31 4.2.9 GENOMIC DNA EXTRACTION AND SEQUENCING ........................................................ 31 4.2.10 BIOACTIVITY TESTS ............................................................................................... 31 4.2.10.1 AGAR-DIFFUSION ASSAYS .................................................................................. 31 4.2.10.2 MICRO-DILUTION ASSAY FOR THE DETERMINATION OF MIC VALUES ....................... 32 4.2.10.3 CYTOTOXICITY ................................................................................................. 32 5 RESULTS AND DISCUSSION..........................................................................................................33 5.1 CYATHANE XYLOSIDES FROM LAXITEXTUM INCRUSTATUM .................................................... 33 5.1.1 BIOACTIVITY GUIDED ISOLATION ................................................................................ 33 5.1.2 STRUCTURE ELUCIDATION AND CHARACTERIZATION ....................................................... 34 5.1.2.1 HPLC-ESI-MASS SPECTROMETRY OF THE LAXITEXTINE COMPOUNDS ..................... 34 5.1.2.2 NMR SPECTROSCOPIC ANALYSIS OF COMPOUND 1 (LAXITEXTINE A) ..................... 35 5.1.2.3 NMR ANALYSIS OF COMPOUND 2 (LAXITEXTINE B) ............................................ 41 5.1.2.4 PHYSICO-CHEMICAL PROPERTIES OF LAXITEXTINES A AND B ................................. 47 5.1.3 BIOSYNTHESIS OF LAXITEXTINE A AND B (CYATHANE DERIVATIVES) .............................. 47 5.1.4 ANTIBACTERIAL ACTIVITY........................................................................................... 49 5.1.5 CYTOTOXICITY...........................................................................................................50 5.2 ANGUCYCLINONE AND ANTHRACYCLINES FROM STREPTOMYCES RK57...................................51 5.2.1 ANGUCYCLINONE: ISOLATION AND CHEMICAL CHARACTERIZATION....................................51 5.2.1.1 HPLC-ESI-MASS SPECTROMETRY OF ANGUCYCLINONE ......................................... 51 5.2.1.2 NMR ANALYSIS OF ANGUCYCLINONE...................................................................52 5.2.2 ANTHRACYCLINES: ISOLATION AND CHEMICAL CHARACTERIZATION....................................58 5.2.2.1 HPLC-ESI-MASS SPECTROMETRY OF ANTHRACYCLINE RK57A AND RK57B ............. 58 5.2.2.2 NMR SPECTROSCOPIC ANALYSIS OF THE ANTHRACYCLINE RK57A............................59 5.2.23 NMR ANALYSIS OF THE ANTHRACYCLINE RK57B .................................................. 62 5.2.3 BIOSYNTHESIS OF THE ANGUCYCLIN(ON)E AND ANTHRACYCLIN(ON)E...............................65 5.2.3.1 BIOSYNTHESIS OF THE AGLYCON..........................................................................66 5.23.2 BIOSYNTHESIS OF DEOXYSUGARS........................................................................ 66 5.2.4 BIOLOGICAL ACTIVITY..................................................................................................67 5.3 NOURSAMYCIN PEPTIDES FROM STREPTOMYCES NOURSEI NTR-SR4....................................68 5.3.1 HPLC-ESI-MASS SPECTROMETRY OF NOURSAMYCINS..................................................68 5.3.2 SPECTRAL NETWORKING ANALYSIS............................................................................... 73 5.3.3 STRUCTURE ELUCIDATION OF THE ISOLATED NOURSAMYCIN PEPTIDES ............................. 74 5.3.4 AMINO ACID ANALYSIS OF PEPTIDES A AND B USING GC-MS.......................................82 5.3.5 BIOSYNTHESIS OF NOURSAMYCINS............................................................................. 83 5.3.6 BIOLOGICAL ACTIVITY................................................................................................. 87 5.4 GRISEMYCIN DERIVATIVES - LINARIDIN PEPTIDES FROM STREPTOMYCES SP. T002 ............... 89 5.4.1 IDENTIFICATION OF NEW METABOLITES 89 5.4.2 HPLC-ESI-MASS SPECTROMETRY OF THE 1768 DA PEPTIDE ...................................... 91 5.4.3 STRUCTURE ELUCIDATION OF THE 1768 DA PEPTIDE..................................................93 5.4.4 AMINO ACID ANALYSIS OF THE 1768 DA PEPTIDE ..................................................... 94 5.4.5 IDENTIFICATION OF THE PUTATIVE BIOSYNTHETIC GENE CLUSTER .................................... 94 5.4.6 BIOLOGICAL ACTIVITY.................................................................................................95 6 CONCLUSIONS AND FUTURE PERSPECTIVES...................................................................................96 7 REFERENCES................................................................................................................................ 98 8 APPENDIX.................................................................................................................................107
any_adam_object 1
author Mudalungu, Cynthia Muhavi
author_GND (DE-588)1165269198
author_facet Mudalungu, Cynthia Muhavi
author_role aut
author_sort Mudalungu, Cynthia Muhavi
author_variant c m m cm cmm
building Verbundindex
bvnumber BV045145837
ctrlnum (OCoLC)1136393167
(DE-599)DNB1161487891
format Thesis
Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01576nam a2200349 c 4500</leader><controlfield tag="001">BV045145837</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">180823s2018 gw |||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">18,H08</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1161487891</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1136393167</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1161487891</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-83</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mudalungu, Cynthia Muhavi</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1165269198</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species</subfield><subfield code="c">vorgelegt von M.Sc. Cynthia Muhavi Mudalungu, aus Kakamega, Kenia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">vi, 134 Seiten</subfield><subfield code="b">Diagramme</subfield><subfield code="c">21 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Technische Universität Berlin</subfield><subfield code="d">2018</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1161487891/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://verlag.tu-berlin.de/abstracts/diss/mudalungu_cynthia_abstract.pdf</subfield><subfield code="3">Abstract</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://verlag.tu-berlin.de/abstracts/diss/mudalungu_cynthia_inhalt.pdf</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=030535590&amp;sequence=000001&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030535590</subfield></datafield></record></collection>
genre (DE-588)4113937-9 Hochschulschrift gnd-content
genre_facet Hochschulschrift
id DE-604.BV045145837
illustrated Not Illustrated
indexdate 2024-12-24T06:50:40Z
institution BVB
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-030535590
oclc_num 1136393167
open_access_boolean
owner DE-83
owner_facet DE-83
physical vi, 134 Seiten Diagramme 21 cm
publishDate 2018
publishDateSearch 2018
publishDateSort 2018
record_format marc
spellingShingle Mudalungu, Cynthia Muhavi
New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species
subject_GND (DE-588)4113937-9
title New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species
title_auth New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species
title_exact_search New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species
title_full New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species vorgelegt von M.Sc. Cynthia Muhavi Mudalungu, aus Kakamega, Kenia
title_fullStr New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species vorgelegt von M.Sc. Cynthia Muhavi Mudalungu, aus Kakamega, Kenia
title_full_unstemmed New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species vorgelegt von M.Sc. Cynthia Muhavi Mudalungu, aus Kakamega, Kenia
title_short New bioactive secondary metabolites from Laxitextum incrustatum (Basidiomycota) and selected Streptomyces species
title_sort new bioactive secondary metabolites from laxitextum incrustatum basidiomycota and selected streptomyces species
topic_facet Hochschulschrift
url http://d-nb.info/1161487891/04
http://verlag.tu-berlin.de/abstracts/diss/mudalungu_cynthia_abstract.pdf
http://verlag.tu-berlin.de/abstracts/diss/mudalungu_cynthia_inhalt.pdf
http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030535590&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv AT mudalungucynthiamuhavi newbioactivesecondarymetabolitesfromlaxitextumincrustatumbasidiomycotaandselectedstreptomycesspecies